HubMed™ Technologies GmBh
HubMed is an AI-powered platform that accelerates R&D for nutraceutical, cosmetic, and medical device companies by automating compound discovery and regulatory compliance. Its integrated ecosystem combines in-silico research with clinical surveillance, reducing time-to-market by up to 70% through machine-reading of scientific literature and PICO-framework-based evidence generation.
- Artificial Intelligence
- Hardware
- Healthcare Technology
- Medical Devices
- Regulatory & Compliance Technology
- Software Only
Funding
Founders
Product
Problem
R&D teams in specialized life sciences face significant bottlenecks due to fragmented workflows between initial compound discovery and final regulatory audit-readiness. Manual molecule ideation and overwhelming volumes of scientific literature slow down innovation and delay market access, particularly for nutraceutical, cosmetic, and medical device companies navigating complex compliance landscapes.
Solution
HubMed provides a unified AI ecosystem that automates high-value scientific processes, integrating in-silico compound discovery with clinical evaluation and post-market surveillance. The platform machine-reads thousands of scientific publications to distill actionable evidence, using the PICO framework to ensure every insight is structured, traceable, and ready for Notified Body audits. By combining these capabilities, HubMed bridges the gap from lab to market, reducing time-to-market by up to 70% and enabling teams to move from manual ideation to evidence-based decision-making.
Target Audience
Primary customers are R&D teams in the nutraceutical, cosmetic, and medical device sectors, as well as Contract Research Organizations (CROs) seeking to enhance operational efficiency, profitability, and audit-readiness.
Features
- Integrated AI ecosystem combining two core modules: Adam™ for in-silico compound discovery and Medea™ for clinical evaluation and regulatory documentation
- Machine-reading engine that processes thousands of scientific publications to extract structured, actionable evidence
- PICO framework implementation ensuring every insight is traceable and audit-ready for Notified Body compliance
- Industry-specific solutions for nutraceuticals (bioactive identification and health claim validation), cosmetics (in-silico safety profiling), medical devices (MDR/IVDR pathways), and CROs (operational efficiency and NB-ready documentation)
- Automated post-market surveillance and Clinical Evaluation Report (CER) generation for streamlined regulatory pathways
- End-to-end integration from discovery through documentation, eliminating the fragmentation gap between research and compliance